Day 1 at the 2017 annual meeting of the American Society of Clinical Oncology demonstrated immunotherapy’s potential to help in treating many different types of cancers. Here are some highlights from data and learnings presented in Chicago.
ASCO17: Day 2 Immunotherapy Highlights
Read Previous Article
ASCO17 Recap: 7 Takeaways from the World’s Premier Clinical Cancer Conference
Read Next Article
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
The changing treatment landscape, new scientific research, and how we’re working toward a future immune to skin cancer.
A changing treatment landscape, new scientific research, and how we’re working toward a future immune to bladder cancer.